MetaVia Inc. (MTVA)
Data as of , from SEC Form 4 filings.
See up to 3 months of MTVA. The 7-day demo opens the 1M and 3M ranges and puts MTVA on your watchlist.
Start 7-day demoLatest MTVA insider trades
About MetaVia Inc. (MTVA)
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
- CAMBRIDGE, MA
- 8
- 2016
- XNAS
MTVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 53,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MTVA insider transactions (Form 4)
1717 Form 4 filings on record, the earliest from Dec 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sarah Kaplan Browne - Officer | Grant or award | Common Stock | 53,000 footnote F1 | $0.00 | - | |
| ||||||
| James Patrick Tursi - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
| D. Gordon Strickland - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
| Michael Salsbury - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
 Jason L. Groves - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
 Andrew I. Koven - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
 Mark A. Glickman - Director | Grant or award | Common Stock | 17,186 footnote F1 | $0.00 | - | |
| ||||||
| Marshall H. Woodworth - Officer | Grant or award | Common Stock | 28,000 footnote F1 | $0.00 | - | |
| ||||||
| Hyung Heon Kim - Officer | Grant or award | Common Stock | 32,000 footnote F1 | $0.00 | - | |
| ||||||
| Marshall H. Woodworth - Officer | Gift | Common Stock | 14,200 | $0.00 | - | |
| Michael Salsbury - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| James Patrick Tursi - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| Jason L. Groves - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| Mark A. Glickman - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| Andrew I. Koven - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| D. Gordon Strickland - Director | Grant or award | Common Stock | 28,147 | $0.00 | - | |
| Hyung Heon Kim - Officer | Tax withholding / forfeiture | Common Stock | 2,867 | $28.05 | $7K | |
MTVA insider trading FAQ
What is the latest insider trade for MTVA?
MetaVia Inc. (MTVA) had 1 insider filing in the last 90 days, with the most recent on 2026-10-13. The full record for MTVA runs to 17 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MTVA stock?
No insider purchases of MTVA were filed in the last 90 days.
How many insiders are selling MTVA stock?
No insider sales of MTVA were filed in the last 90 days.
Where can I see MTVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MTVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Sarah Kaplan Browne view on EDGAR
- - James Patrick Tursi view on EDGAR
- - D. Gordon Strickland view on EDGAR
- - Michael Salsbury view on EDGAR
- - Jason L. Groves view on EDGAR
- - Andrew I. Koven view on EDGAR
- - Mark A. Glickman view on EDGAR
- - Marshall H. Woodworth view on EDGAR
- - Hyung Heon Kim view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MTVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MTVA with a 7-day demo
- MTVA on your watchlist
- Every MTVA Form 4 filing on record
- Up to 3 months of MTVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
